Profiling cell envelope-antibiotic interactions reveals vulnerabilities to β-lactams in a multidrug-resistant bacterium

• Published in: Nature communications 2023-08, Vol.14 (1), p.4815-4815, Article 4815
• Main Authors: Hogan, Andrew M., Rahman, A. S. M. Zisanur, Motnenko, Anna, Natarajan, Aakash, Maydaniuk, Dustin T., León, Beltina, Batun, Zayra, Palacios, Armando, Bosch, Alejandra, Cardona, Silvia T.
• Format: Article
• Language: English
• Subjects: 38; 38/77; 45; 49; 49/23; 631/326/22/1290; 631/326/22/1434; 631/326/41; 631/326/421; Amides; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Antibiotics; Antiinfectives and antibacterials; Aztreonam; Bacteria; beta-Lactamase Inhibitors - pharmacology; beta-Lactamases - metabolism; Burkholderia cenocepacia; Carbapenemase; Ceftazidime; Ceftazidime - pharmacology; Cephalosporins; Clinical isolates; CRISPR; Drug Combinations; Drug resistance; Genomes; Gram-negative bacteria; Humanities and Social Sciences; Humans; Meropenem; Microbial Sensitivity Tests; multidisciplinary; Multidrug resistance; Multidrug resistant organisms; Mutants; Penetration resistance; Peptidoglycans; Science; Science (multidisciplinary); Susceptibility; β Lactamase; β-Lactam antibiotics
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-023-40494-5

The cell envelope of Gram-negative bacteria belonging to the Burkholderia cepacia complex (Bcc) presents unique restrictions to antibiotic penetration. As a consequence, Bcc species are notorious for causing recalcitrant multidrug-resistant infections in immunocompromised individuals. Here, we present the results of a genome-wide screen for cell envelope-associated resistance and susceptibility determinants in a Burkholderia cenocepacia clinical isolate. For this purpose, we construct a high-density, randomly-barcoded transposon mutant library and expose it to 19 cell envelope-targeting antibiotics. By quantifying relative mutant fitness with BarSeq, followed by validation with CRISPR-interference, we profile over a hundred functional associations and identify mediators of antibiotic susceptibility in the Bcc cell envelope. We reveal connections between β-lactam susceptibility, peptidoglycan synthesis, and blockages in undecaprenyl phosphate metabolism. The synergy of the β-lactam/β-lactamase inhibitor combination ceftazidime/avibactam is primarily mediated by inhibition of the PenB carbapenemase. In comparison with ceftazidime, avibactam more strongly potentiates the activity of aztreonam and meropenem in a panel of Bcc clinical isolates. Finally, we characterize in Bcc the iron and receptor-dependent activity of the siderophore-cephalosporin antibiotic, cefiderocol. Our work has implications for antibiotic target prioritization, and for using additional combinations of β-lactam/β-lactamase inhibitors that can extend the utility of current antibacterial therapies. The bacterial pathogen Burkholderia cenocepacia and related species are often multidrug resistant because their cell envelope restricts antibiotic penetration. Here, Hogan et al systematically identify genes associated with resistance and susceptibility to cell envelope-targeting antibiotics, providing insights into underlying mechanisms and suggesting avenues for development of improved antibacterial therapies.